About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Study of ZIO-101 in Multiple Myeloma

NCT00303199·8 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Alaunos Therapeutics

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Subjects with multiple myeloma who have received at least two prior therapies and currently require therapy.

The record

StatusCompleted

PhasePhase 1–2

Taking part35

StartedJan 2006

UpdatedJul 19, 2012

Conditions

Multiple Myeloma

Where8

Little Rock, Arkansas, United States
West Hollywood, California, United States
Miami, Florida, United States

Clareo Health | Study of ZIO-101 in Multiple Myeloma